Tamara McGrillen | Head of IR |
Dr. Geert Cauwenbergh | CEO |
Dr. Gerrit Dispersyn | Chief Development Officer |
Dr. Karen Bulock | Vice President of Research |
Caitlin Kontulis | Principal Accounting Officer |
Carmelo Cataudella | Aegis Capital |
Good day ladies and gentlemen and welcome to today's webcast entitled RXi Pharmaceuticals Third Quarter 2017 Financial Results Earning Call. Today's call is being recorded. At this time, it is my pleasure to turn the floor over to your host, Tamara McGrillen, Head of Investor Relations for RXi. Ma'am, the floor is yours.
Thank you very much operator and good afternoon ladies and gentlemen.